PATIENT SQUARE CAPITAL, LP

Thesis

Patient Square Capital, LP is a specialized investment firm founded in 2020 and exclusively focused on the healthcare industry. The firm's investment thesis centers on improving patient lives, strengthening communities, and creating a healthier world through strategic investments. They employ a flexible strategy encompassing development-stage therapeutics, commercial-stage pharmaceuticals, medical devices, diagnostics, life science tools, healthcare providers, and technology-enabled services. Their approach is characterized by deep industry expertise, a wide network, and a partnership model, focusing on control-oriented investments and growth equity in companies with strong revenue growth potential and a clear mission to enhance patient and consumer health. While investing broadly across healthcare, they show a preference for growth-stage to mature buyout opportunities. Their geographic scope is primarily the United States, with some investments in the United Kingdom. The firm closed its inaugural fund with approximately $3.9 billion and reported over $17 billion in AUM as of May 2026. They typically invest between $50 million and $250 million in equity.

Related lists

• Series C+ investors based in Menlo Park, CA